Loading...
Venus Concept Inc.
VERO•NASDAQ
HealthcareMedical - Devices
$2.80
$-0.38(-11.95%)
Venus Concept Inc. (VERO) Financial Performance & Statements
Review Venus Concept Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-15.09%
↓ 15.09%
Operating Income Growth
3.97%
↑ 3.97%
Net Income Growth
-26.16%
↓ 26.16%
Operating Cash Flow Growth
13.94%
↑ 13.94%
Operating Margin
-61.14%
↓ 61.14%
Gross Margin
87.46%
↑ 87.46%
Net Profit Margin
-104.68%
↓ 104.68%
ROE
-1075.17%
↓ 1075.17%
ROIC
163.07%
↑ 163.07%
Venus Concept Inc. (VERO) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Venus Concept Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $15.77M | $15.007M | $16.58M |
| Cost of Revenue | $0.00 | $4.88M | $5.09M | $4.73M |
| Gross Profit | $8.76M | $10.89M | $9.92M | $11.85M |
| Gross Profit Ratio | $0.69 | $0.66 | $0.71 | |
| R&D Expenses | $1.56M | $1.47M | $1.69M | $1.74M |
| SG&A Expenses | $16.73M | $16.09M | $15.39M | $15.71M |
| Operating Expenses | $18.28M | $17.56M | $17.08M | $17.45M |
| Total Costs & Expenses | $0.00 | $22.44M | $22.16M | $22.18M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1.57M | $1.25M | $1.67M | $2.45M |
| Depreciation & Amortization | $0.00 | $965000.00 | $971000.00 | $976000.00 |
| EBITDA | -$9.53M | -$6.56M | -$6.70M | -$16.30M |
| EBITDA Ratio | -$0.42 | -$0.45 | -$0.98 | |
| Operating Income | -$9.53M | -$6.67M | -$7.16M | -$5.60M |
| Operating Income Ratio | -$0.42 | -$0.48 | -$0.34 | |
| Other Income/Expenses (Net) | -$2.50M | -$2.10M | -$2.18M | -$14.13M |
| Income Before Tax | -$12.03M | -$8.77M | -$9.33M | -$19.72M |
| Income Before Tax Ratio | -$0.56 | -$0.62 | -$1.19 | |
| Income Tax Expense | $338000.00 | -$758000.00 | -$31000.00 | $141000.00 |
| Net Income | -$12.37M | -$7.96M | -$9.29M | -$19.95M |
| Net Income Ratio | -$0.51 | -$0.62 | -$1.20 | |
| EPS | -$17.44 | -$11.23 | -$1.28 | -$3.05 |
| Diluted EPS | -$17.44 | -$11.23 | -$1.28 | -$3.05 |
| Weighted Avg Shares Outstanding | $709000.00 | $709000.00 | $7.25M | $6.55M |
| Weighted Avg Shares Outstanding (Diluted) | $709000.00 | $709000.00 | $7.25M | $6.55M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan